Sivik Global Healthcare LLC Acquires Shares of 300,000 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sivik Global Healthcare LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 300,000 shares of the exchange traded fund’s stock, valued at approximately $29,640,000. SPDR S&P Biotech ETF makes up about 12.5% of Sivik Global Healthcare LLC’s holdings, making the stock its largest position. Sivik Global Healthcare LLC owned about 0.39% of SPDR S&P Biotech ETF as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in XBI. Healthcare of Ontario Pension Plan Trust Fund raised its stake in SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after buying an additional 730,000 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of SPDR S&P Biotech ETF by 1.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after purchasing an additional 18,202 shares during the period. Jane Street Group LLC lifted its stake in shares of SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares during the period. Bessemer Group Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 1.7% in the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after buying an additional 15,794 shares during the last quarter. Finally, Employees Retirement System of Texas grew its position in SPDR S&P Biotech ETF by 40.8% during the second quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock valued at $55,984,000 after buying an additional 174,857 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $100.32 on Thursday. The stock has a market capitalization of $7.65 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $69.32 and a 1-year high of $105.47. The company’s fifty day simple moving average is $99.07 and its 200-day simple moving average is $95.98.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.